Showing 1931-1940 of 4065 results for "".
Cases From the Real World: 61-Year-Old With Wet AMD With a High Treatment Burden
https://reachmd.com/programs/cme/Cases-From-the-Real-World-61-Year-Old-With-Wet-AMD-With-a-High-Treatment-Burden/33169/Join Drs. Ted Leng and Danny Mammo as they explore their real-world experience with second-generation retinal agents for nAMD.Next-Generation Horizons in PNH Therapies
https://reachmd.com/programs/project-oncology/next-generation-horizons-in-pnh-therapies/48873/What can we expect from PNH therapies that are on the horizon? Tune in to learn more.Exploring Patient Perspectives on Genetic Testing for ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/exploring-patient-perspectives-on-genetic-testing-for-attr-cm/39317/Genetic testing is a very valuable tool in managing transthyretin amyloid cardiomyopathy (ATTR-CM), but many patients face emotional, educational, and systemic barriers throughout. To learn more about the patient perspective of this process, researchers conducted interviews with ATTR-CM patients andPrimary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
https://reachmd.com/clinical-practice/cardiology/primary-results-of-the-vesalius-cv-trial-evolocumab-in-patients-at-high-cardiovascular-risk-without-prior-mi-or-stroke/45568/Dr. Erin Bohula reviews VESALIUS-CV trial findings on evolocumab for primary Cardiovascular prevention in patients at high CV risk without prior MI or stroke.Targeting Variability: A New Look at Systemic Therapies in Pediatric Severe Atopic Dermatitis
https://reachmd.com/programs/dermconsult/targeting-variability-a-new-look-at-systemic-therapies-in-pediatric-severe-atopic-dermatitis/36439/Analyzing a Mobile App’s Impacts on COVID-19 Vaccine Trust in Young Black Adults
https://reachmd.com/programs/clinicians-roundtable/analyzing-a-mobile-apps-impacts-on-covid-19-vaccine-trust-in-young-black-adults/36411/Unmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
https://reachmd.com/programs/living-rheum/unmasking-igg4-related-disease-best-practices-for-accurate-diagnosis-and-optimal-care/32788/IgG4-related disease presents significant diagnostic challenges with diverse symptoms across organ systems. Dr. Matthew Baker, Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Founder and Co-Director of the Stanford Multidisciplinary SarcoidosThe Psychosocial Dermal Axis
https://reachmd.com/topics/skincare/the-psychosocial-dermal-axis/35421/It’s time for psychiatry, dermatology, and aesthetic medicine to unite and explore.How Can I Beat the Summer Slump?
https://reachmd.com/topics/practice-development/how-can-i-beat-the-summer-slump/35193/Expert advice on how to use downtime to your advantageNew Product Evaluation Basics in Aesthetic Practices
https://reachmd.com/topics/injectables/new-product-evaluation-basics-in-aesthetic-practices/35166/Choice of methodology can lead to widely different conclusions: A single-center experience.